Shopping Cart 0
Cart Subtotal
AED 0

Asia-Pacific Radiotherapy Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2024

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 15414

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 19818

Details

The Asia-Pacific Radiotherapy Market has accounted for USD 1.1 billion in 2016 and is expected to reach USD 2.4 billion by 2024, growing at a CAGR 10.3% during the forecast period 2017 to 2024.
 
Cancer is the major cause of death in the world and the number of new patients each year is steadily increasing. The most common form of cancer mortality is by metastasis, where the tumors and cancerous cells spread to organs causing failure. The world is focused upon developing solutions and cure to cancer by destroying primary and secondary tumors that cause metastasis.
 
The key market players for Asia-Pacific Radiotherapy Market are listed below:
 
Varian Medical Systems, Inc.
CIVCO Medical Solutions
Elekta AB
Nanobiotix,
Accuray Incorporated
Brainlab AG
Ion Beam Applications SA
C. R. Bard, Inc.
IsoRay Medical, Inc.
TRF, Nordion, Inc.
RaySearch Laboratories AB
PRECISIS AG
Mevion Medical Systems, Inc.
Mitsubishi Electric Corporation
  
The market is further segmented into:
Therapy
Product
Application
Product Type
Geography
 
The Asia-pacific radiotherapy market is segmented based on therapy, product, application, and geography. Based on the therapy, the radiotherapy market is segmented into external beam radiotherapy, internal beam radiotherapy, and systemic radiation therapy.
Based on the delivery of dose-rate, internal beam therapy is divided into low (LDR) and high-dose-rate (HDR). The LDR segment is expected to account for the largest share of the internal radiotherapy/brachytherapy market, whereas the HDR segment is poised to witness the highest growth.
Based on product type the Asia-Pacific radiotherapy market is segmented into EBRT equipment and IBRT equipment.
The External Beam Radiotherapy (EBRT) products are further segmented into cyberknife, gamma knife, LINAC, Proton Beam (Cyclotron, Synclotron).
The Internal Beam Radiotherapy (IBRT) is segmented into seeds, after leaders and others.
The Asia-Pacific radiotherapy market is also segmented based on indication into cancer of different organs such as brain tumor, spine cancer, lung cancer, liver cancer, breast cancer, prostate cancer, and others.
 
Based on geography, the Asia-Pacific Radiotherapy market is segmented into 11 geographical regions, such as,
China
Japan
India
South Korea
Australia
Thailand
Malaysia
Singapore
Indonesia
Philippines
 
Covered in this report
The report covers the present scenario and the growth prospects of the Asia-Pacific Radiotherapy market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.
You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.
READ MORE

Table Of Content

Scope

Table Of Contents

1 Introduction

1.1. Overview Of The Asia-Pacific Radiotherapy Market

1.2. Currency And Pricing

1.3. Limitation

1.4. Markets Covered

2 Market Segmentation

2.1. Key Takeaways

2.2. Arriving At The Asia-Pacific Radiotherapy Market Size

2.2.1 Vendor Positioning Grid

2.2.2 Technology Life Line Curve

2.2.3 Market Time Line

2.2.4 Market Guide

2.2.5 Company Positioning Grid

2.2.6 Comapany Market Share Analysis

2.2.7 Multivariate Modelling

2.2.8 Standards Of Measurement

2.2.9 Top To Bottom Analysis

2.2.10 Vendor Share Analysis

2.2.11 Data Points From Key Primary Interviews

2.2.12 Data Points From Key Secondary Databases

2.3. Asia-Pacific Radiotherapy Market: Research Snapshot

2.4. Assumptions

3 Market Overview

3.1. Drivers

3.2. Restraints

3.3. Opportunities

3.4. Challenges

4 Executive Summary

5 Premium Insights

5.1. Vendor Positioning Grid And Investment Opportunities

5.2. Technololgical Advancements

5.3. Insights On Technological Developments In The Asia-Pacific Radiotherapy Market Market

5.4. Market Regulatory Scenario By Country

5.5. Interview Key Insights

6 Asia-Pacific Radiotherapy Market, By Therapy

7 Asia-Pacific Radiotherapy Market, By Product

8 Asia-Pacific Radiotherapy Market, By Technology

9 Asia-Pacific Radiotherapy Market, By Application

10 Asia-Pacific Radiotherapy Market: Geography

 

11 Asia-Pacific Radiotherapy Market, Company Profiles

11.1 Varian Medical Systems, Inc

11.2 Civco Medical Solutions

11.3 Elekta Ab

11.4 Nanobiotix

11.5 Accuray Incorporated

11.6 Company A

11.7 Company B

11.8 Company C

11.9 Company D

11.10 Company E

11.11 Company F

11.12 Company G

11.13 Company H

11.14 Company I

11.15 Company J

11.16 Company K

11.17 Company M

11.18 Company N

11.19 Company O

12 Appendix

13 About Data Bridge Market Research

 

Licence Rights

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies


Companies

Varian Medical Systems, Inc.,

CIVCO Medical Solutions,

Elekta AB,

Nanobiotix,

Accuray Incorporated,

Brainlab AG,

Ion Beam Applications SA,

C. R. Bard, Inc.,

IsoRay Medical, Inc.,

TRF, Nordion, Inc.,

RaySearch Laboratories AB,

PRECISIS AG,

Mevion Medical Systems, Inc.,

Mitsubishi Electric Corporation

Company Profile

Company Profile Title

The Asia-Pacific Radiotherapy Market has accounted for USD 1.1 billion in 2016 and is expected to reach USD 2.4 billion by 2024, growing at a CAGR 10.3% during the forecast period 2017 to 2024.
 
Cancer is the major cause of death in the world and the number of new patients each year is steadily increasing. The most common form of cancer mortality is by metastasis, where the tumors and cancerous cells spread to organs causing failure. The world is focused upon developing solutions and cure to cancer by destroying primary and secondary tumors that cause metastasis.
 
The key market players for Asia-Pacific Radiotherapy Market are listed below:
 
Varian Medical Systems, Inc.
CIVCO Medical Solutions
Elekta AB
Nanobiotix,
Accuray Incorporated
Brainlab AG
Ion Beam Applications SA
C. R. Bard, Inc.
IsoRay Medical, Inc.
TRF, Nordion, Inc.
RaySearch Laboratories AB
PRECISIS AG
Mevion Medical Systems, Inc.
Mitsubishi Electric Corporation
  
The market is further segmented into:
Therapy
Product
Application
Product Type
Geography
 
The Asia-pacific radiotherapy market is segmented based on therapy, product, application, and geography. Based on the therapy, the radiotherapy market is segmented into external beam radiotherapy, internal beam radiotherapy, and systemic radiation therapy.
Based on the delivery of dose-rate, internal beam therapy is divided into low (LDR) and high-dose-rate (HDR). The LDR segment is expected to account for the largest share of the internal radiotherapy/brachytherapy market, whereas the HDR segment is poised to witness the highest growth.
Based on product type the Asia-Pacific radiotherapy market is segmented into EBRT equipment and IBRT equipment.
The External Beam Radiotherapy (EBRT) products are further segmented into cyberknife, gamma knife, LINAC, Proton Beam (Cyclotron, Synclotron).
The Internal Beam Radiotherapy (IBRT) is segmented into seeds, after leaders and others.
The Asia-Pacific radiotherapy market is also segmented based on indication into cancer of different organs such as brain tumor, spine cancer, lung cancer, liver cancer, breast cancer, prostate cancer, and others.
 
Based on geography, the Asia-Pacific Radiotherapy market is segmented into 11 geographical regions, such as,
China
Japan
India
South Korea
Australia
Thailand
Malaysia
Singapore
Indonesia
Philippines
 
Covered in this report
The report covers the present scenario and the growth prospects of the Asia-Pacific Radiotherapy market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.
You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.
READ MORE

Scope

Table Of Contents

1 Introduction

1.1. Overview Of The Asia-Pacific Radiotherapy Market

1.2. Currency And Pricing

1.3. Limitation

1.4. Markets Covered

2 Market Segmentation

2.1. Key Takeaways

2.2. Arriving At The Asia-Pacific Radiotherapy Market Size

2.2.1 Vendor Positioning Grid

2.2.2 Technology Life Line Curve

2.2.3 Market Time Line

2.2.4 Market Guide

2.2.5 Company Positioning Grid

2.2.6 Comapany Market Share Analysis

2.2.7 Multivariate Modelling

2.2.8 Standards Of Measurement

2.2.9 Top To Bottom Analysis

2.2.10 Vendor Share Analysis

2.2.11 Data Points From Key Primary Interviews

2.2.12 Data Points From Key Secondary Databases

2.3. Asia-Pacific Radiotherapy Market: Research Snapshot

2.4. Assumptions

3 Market Overview

3.1. Drivers

3.2. Restraints

3.3. Opportunities

3.4. Challenges

4 Executive Summary

5 Premium Insights

5.1. Vendor Positioning Grid And Investment Opportunities

5.2. Technololgical Advancements

5.3. Insights On Technological Developments In The Asia-Pacific Radiotherapy Market Market

5.4. Market Regulatory Scenario By Country

5.5. Interview Key Insights

6 Asia-Pacific Radiotherapy Market, By Therapy

7 Asia-Pacific Radiotherapy Market, By Product

8 Asia-Pacific Radiotherapy Market, By Technology

9 Asia-Pacific Radiotherapy Market, By Application

10 Asia-Pacific Radiotherapy Market: Geography

 

11 Asia-Pacific Radiotherapy Market, Company Profiles

11.1 Varian Medical Systems, Inc

11.2 Civco Medical Solutions

11.3 Elekta Ab

11.4 Nanobiotix

11.5 Accuray Incorporated

11.6 Company A

11.7 Company B

11.8 Company C

11.9 Company D

11.10 Company E

11.11 Company F

11.12 Company G

11.13 Company H

11.14 Company I

11.15 Company J

11.16 Company K

11.17 Company M

11.18 Company N

11.19 Company O

12 Appendix

13 About Data Bridge Market Research

 

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS


Companies

Varian Medical Systems, Inc.,

CIVCO Medical Solutions,

Elekta AB,

Nanobiotix,

Accuray Incorporated,

Brainlab AG,

Ion Beam Applications SA,

C. R. Bard, Inc.,

IsoRay Medical, Inc.,

TRF, Nordion, Inc.,

RaySearch Laboratories AB,

PRECISIS AG,

Mevion Medical Systems, Inc.,

Mitsubishi Electric Corporation